Detalhe da pesquisa
1.
Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19.
BMC Urol
; 22(1): 71, 2022 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488333